Seeking Alpha

Enzo Biochem (ENZ -9.3%) takes a hit after its FQ1 misses across the board. Net losses widened...

Enzo Biochem (ENZ -9.3%) takes a hit after its FQ1 misses across the board. Net losses widened Y/Y, as royalty payments declined and operating expenses jumped 11% due to higher SG&A expenses.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs